Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial
暂无分享，去创建一个
A. Schneeweiss | F. Marmé | J. Albanell | S. Di Cosimo | A. Llombart-Cussac | P. Schmid | F. Dalenc | V. Carañana | J. Gligorov | J. Cortés | P. Zamora | M. Bellet | J. Gavilá | M. G. Gil Gil | A. Malfettone | D. Wheatley | M. Sampayo-Cordero | M. Ruíz Borrego | E. Aguirre | K. Amillano | L. Mina | J. Peréz-García | Eduardo Martínez-de Dueñas